105 related articles for article (PubMed ID: 37205500)
21. Highly elevated polygenic risk scores are better predictors of myocardial infarction risk early in life than later.
Isgut M; Sun J; Quyyumi AA; Gibson G
Genome Med; 2021 Jan; 13(1):13. PubMed ID: 33509272
[TBL] [Abstract][Full Text] [Related]
22. Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians.
Wünnemann F; Sin Lo K; Langford-Avelar A; Busseuil D; Dubé MP; Tardif JC; Lettre G
Circ Genom Precis Med; 2019 Jun; 12(6):e002481. PubMed ID: 31184202
[TBL] [Abstract][Full Text] [Related]
23. Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.
Agbaedeng TA; Noubiap JJ; Mofo Mato EP; Chew DP; Figtree GA; Said MA; van der Harst P
Atherosclerosis; 2021 Sep; 333():48-55. PubMed ID: 34425527
[TBL] [Abstract][Full Text] [Related]
24. Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians.
Tam CHT; Lim CKP; Luk AOY; Ng ACW; Lee HM; Jiang G; Lau ESH; Fan B; Wan R; Kong APS; Tam WH; Ozaki R; Chow EYK; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JKY; Yeung VTF; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Hu M; Yu W; Tsui SKW; Huang Y; Lan H; Szeto CC; Tang NLS; Ng MCY; So WY; Tomlinson B; Chan JCN; Ma RCW; ;
Genome Med; 2021 Feb; 13(1):29. PubMed ID: 33608049
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Polygenic Risk Scores for Prediction of Coronary Artery Disease in a Greek Case-Control Study.
Dimitriou M; Moulos P; Kalafati IP; Saranti G; Rallidis LS; Dedoussis GV
J Pers Med; 2024 May; 14(6):. PubMed ID: 38929788
[TBL] [Abstract][Full Text] [Related]
26. Assessing the prediction of type 2 diabetes risk using polygenic and clinical risk scores in South Asian study populations.
Rout M; Wander GS; Ralhan S; Singh JR; Aston CE; Blackett PR; Chernausek S; Sanghera DK
Ther Adv Endocrinol Metab; 2023; 14():20420188231220120. PubMed ID: 38152657
[TBL] [Abstract][Full Text] [Related]
27. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study.
Lindbohm JV; Sipilä PN; Mars N; Knüppel A; Pentti J; Nyberg ST; Frank P; Ahmadi-Abhari S; Brunner EJ; Shipley MJ; Singh-Manoux A; Tabak AG; Batty GD; Kivimäki M
Lancet Digit Health; 2021 Jul; 3(7):e434-e444. PubMed ID: 34167764
[TBL] [Abstract][Full Text] [Related]
28. Polygenic Risk Score, Lifestyles, and Type 2 Diabetes Risk: A Prospective Chinese Cohort Study.
Liu J; Wang L; Cui X; Shen Q; Wu D; Yang M; Dong Y; Liu Y; Chen H; Yang Z; Liu Y; Zhu M; Ma H; Jin G; Qian Y
Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432247
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
[TBL] [Abstract][Full Text] [Related]
30. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.
Lu X; Liu Z; Cui Q; Liu F; Li J; Niu X; Shen C; Hu D; Huang K; Chen J; Xing X; Zhao Y; Lu F; Liu X; Cao J; Chen S; Ma H; Yu L; Wu X; Wu X; Li Y; Zhang H; Mo X; Zhao L; Huang J; Wang L; Wen W; Shu XO; Takeuchi F; Koh WP; Tai ES; Cheng CY; Wong TY; Chang X; Chan MY; Gao W; Zheng H; Chen K; Chen J; He J; Tang CS; Lam KSL; Tse HF; Cheung CYY; Takahashi A; Kubo M; Kato N; Terao C; Kamatani Y; Sham PC; Heng CK; Hu Z; Chen YE; Wu T; Shen H; Willer CJ; Gu D
Eur Heart J; 2022 May; 43(18):1702-1711. PubMed ID: 35195259
[TBL] [Abstract][Full Text] [Related]
31. Predictive Performance of a Polygenic Risk Score for Incident Ischemic Stroke in a Healthy Older Population.
Neumann JT; Riaz M; Bakshi A; Polekhina G; Thao LTP; Nelson MR; Woods RL; Abraham G; Inouye M; Reid CM; Tonkin AM; Williamson JD; Donnan GA; Brodtmann A; Cloud GC; McNeil JJ; Lacaze P
Stroke; 2021 Aug; 52(9):2882-2891. PubMed ID: 34039031
[TBL] [Abstract][Full Text] [Related]
32. Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease.
Aragam KG; Dobbyn A; Judy R; Chaffin M; Chaudhary K; Hindy G; Cagan A; Finneran P; Weng LC; Loos RJF; Nadkarni G; Cho JH; Kember RL; Baras A; Reid J; Overton J; Philippakis A; Ellinor PT; Weiss ST; Rader DJ; Lubitz SA; Smoller JW; Karlson EW; Khera AV; Kathiresan S; Do R; Damrauer SM; Natarajan P
J Am Coll Cardiol; 2020 Jun; 75(22):2769-2780. PubMed ID: 32498804
[TBL] [Abstract][Full Text] [Related]
33. The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia.
Gallo A; Pérez de Isla L; Charrière S; Vimont A; Alonso R; Muñiz-Grijalvo O; Díaz-Díaz JL; Zambón D; Moulin P; Bruckert E; Mata P; Béliard S;
JACC Cardiovasc Imaging; 2021 Dec; 14(12):2414-2424. PubMed ID: 34274263
[TBL] [Abstract][Full Text] [Related]
34. Meta-Prediction of Coronary Artery Disease Risk.
Torkamani A; Chen SF; Lee SE; Sadaei H; Park JB; Khattab A; Henegar C; Wineinger N; Muse E
Res Sq; 2023 Dec; ():. PubMed ID: 38196609
[TBL] [Abstract][Full Text] [Related]
35. Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study.
Sattar N; McMurray J; Borén J; Rawshani A; Omerovic E; Berg N; Halminen J; Skoglund K; Eliasson B; Gerstein HC; McGuire DK; Bhatt D; Rawshani A
Circulation; 2023 Jun; 147(25):1872-1886. PubMed ID: 37154040
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
Triant VA; Perez J; Regan S; Massaro JM; Meigs JB; Grinspoon SK; D'Agostino RB
Circulation; 2018 May; 137(21):2203-2214. PubMed ID: 29444987
[TBL] [Abstract][Full Text] [Related]
37. Contemporary Cardiovascular Risk Assessment for Type 2 Diabetes Including Heart Failure as an Outcome: The Fremantle Diabetes Study Phase II.
Davis WA; Hellbusch V; Hunter ML; Bruce DG; Davis TME
J Clin Med; 2020 May; 9(5):. PubMed ID: 32403446
[No Abstract] [Full Text] [Related]
38. Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention program.
Mujwara D; Kintzle J; Di Domenico P; Busby GB; Bottà G
Front Public Health; 2023; 11():1139496. PubMed ID: 37497026
[TBL] [Abstract][Full Text] [Related]
39. Application of hyperglycemia/diabetes-derived polygenic risk scores on the risk of poor outcomes after an ischemic stroke.
Chen YL; Chi NF; Chiou HY; Hu CJ; Jeng JS; Tang SC; Lin HJ; Hsieh YC;
J Chin Med Assoc; 2022 Jan; 85(1):81-87. PubMed ID: 35006127
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
